Wu T - Search Results

1

Augmented capacity for peripheral serotonin release in human obesity.

Young RL, Lumsden AL, Martin AM, Schober G, Pezos N, Thazhath SS, Isaacs NJ, Cvijanovic N, Sun EWL, Wu T, Rayner CK, Nguyen NQ, Fontgalland D, Rabbitt P, Hollington P, Sposato L, Due SL, Wattchow DA, Liou AP, Jackson VM, Keating DJ. Young RL, et al. Among authors: wu t. Int J Obes (Lond). 2018 Nov;42(11):1880-1889. doi: 10.1038/s41366-018-0047-8. Epub 2018 Mar 1. Int J Obes (Lond). 2018. PMID: 29568107

2

Dietary effects on incretin hormone secretion.

Wu T, Rayner CK, Jones K, Horowitz M. Wu T, et al. Vitam Horm. 2010;84:81-110. doi: 10.1016/B978-0-12-381517-0.00003-5. Vitam Horm. 2010. PMID: 21094897 Review.

3

Effects of different sweet preloads on incretin hormone secretion, gastric emptying, and postprandial glycemia in healthy humans.

Wu T, Zhao BR, Bound MJ, Checklin HL, Bellon M, Little TJ, Young RL, Jones KL, Horowitz M, Rayner CK. Wu T, et al. Am J Clin Nutr. 2012 Jan;95(1):78-83. doi: 10.3945/ajcn.111.021543. Epub 2011 Dec 7. Am J Clin Nutr. 2012. PMID: 22158727 Free article. Clinical Trial.

4

Effects of rectal administration of taurocholic acid on glucagon-like peptide-1 and peptide YY secretion in healthy humans.

Wu T, Bound MJ, Standfield SD, Gedulin B, Jones KL, Horowitz M, Rayner CK. Wu T, et al. Diabetes Obes Metab. 2013 May;15(5):474-7. doi: 10.1111/dom.12043. Epub 2012 Dec 17. Diabetes Obes Metab. 2013. PMID: 23181598

5

Effects of a D-xylose preload with or without sitagliptin on gastric emptying, glucagon-like peptide-1, and postprandial glycemia in type 2 diabetes.

Wu T, Bound MJ, Zhao BR, Standfield SD, Bellon M, Jones KL, Horowitz M, Rayner CK. Wu T, et al. Diabetes Care. 2013 Jul;36(7):1913-8. doi: 10.2337/dc12-2294. Epub 2013 Jan 28. Diabetes Care. 2013. PMID: 23359361 Free PMC article. Clinical Trial.

6

Effects of taurocholic acid on glycemic, glucagon-like peptide-1, and insulin responses to small intestinal glucose infusion in healthy humans.

Wu T, Bound MJ, Standfield SD, Jones KL, Horowitz M, Rayner CK. Wu T, et al. J Clin Endocrinol Metab. 2013 Apr;98(4):E718-22. doi: 10.1210/jc.2012-3961. Epub 2013 Feb 15. J Clin Endocrinol Metab. 2013. PMID: 23418316 Clinical Trial.

7

Effects of intraduodenal glutamine on incretin hormone and insulin release, the glycemic response to an intraduodenal glucose infusion, and antropyloroduodenal motility in health and type 2 diabetes.

Chang J, Wu T, Greenfield JR, Samocha-Bonet D, Horowitz M, Rayner CK. Chang J, et al. Among authors: wu t. Diabetes Care. 2013 Aug;36(8):2262-5. doi: 10.2337/dc12-1663. Epub 2013 Apr 5. Diabetes Care. 2013. PMID: 23564914 Free PMC article. Clinical Trial.

8

Disordered control of intestinal sweet taste receptor expression and glucose absorption in type 2 diabetes.

Young RL, Chia B, Isaacs NJ, Ma J, Khoo J, Wu T, Horowitz M, Rayner CK. Young RL, et al. Among authors: wu t. Diabetes. 2013 Oct;62(10):3532-41. doi: 10.2337/db13-0581. Epub 2013 Jun 12. Diabetes. 2013. PMID: 23761104 Free PMC article. Clinical Trial.

9

Gut motility and enteroendocrine secretion.

Wu T, Rayner CK, Young RL, Horowitz M. Wu T, et al. Curr Opin Pharmacol. 2013 Dec;13(6):928-34. doi: 10.1016/j.coph.2013.09.002. Epub 2013 Sep 20. Curr Opin Pharmacol. 2013. PMID: 24060702 Review.

10

Artificial sweeteners have no effect on gastric emptying, glucagon-like peptide-1, or glycemia after oral glucose in healthy humans.

Wu T, Bound MJ, Standfield SD, Bellon M, Young RL, Jones KL, Horowitz M, Rayner CK. Wu T, et al. Diabetes Care. 2013 Dec;36(12):e202-3. doi: 10.2337/dc13-0958. Diabetes Care. 2013. PMID: 24265374 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19,119 results

Search Page